Brian O'Callaghan's most recent trade in Bolt Biotherapeutics Inc was a trade of 1,100 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bolt Biotherapeutics Inc | Brian O'Callaghan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 1,100 | 1,100 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | Brian O'Callaghan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | Brian O'Callaghan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | Brian O'Callaghan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 22,140 | 22,140 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | Brian O'Callaghan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 14,071 | 14,071 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | Brian O'Callaghan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 27,860 | 27,860 | - | - | Stock Option (Right to Buy) |